Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
4.11
Dollar change
-0.04
Percentage change
-0.96
%
IndexRUT P/E- EPS (ttm)-0.36 Insider Own8.32% Shs Outstand602.80M Perf Week2.75%
Market Cap2.48B Forward P/E- EPS next Y-0.12 Insider Trans-3.87% Shs Float552.62M Perf Month-7.43%
Income-219.55M PEG- EPS next Q-0.08 Inst Own69.86% Short Float14.26% Perf Quarter-10.07%
Sales1.37M P/S1808.39 EPS this Y-6.25% Inst Trans7.65% Short Ratio9.54 Perf Half Y4.05%
Book/sh0.51 P/B8.05 EPS next Y65.69% ROA-50.78% Short Interest78.83M Perf Year115.18%
Cash/sh0.60 P/C6.81 EPS next 5Y5.00% ROE-72.56% 52W Range1.64 - 5.34 Perf YTD94.79%
Dividend Est.- P/FCF- EPS past 5Y-16.08% ROI-63.48% 52W High-23.03% Beta0.50
Dividend TTM- Quick Ratio3.60 Sales past 5Y46.26% Gross Margin- 52W Low150.61% ATR (14)0.18
Dividend Ex-Date- Current Ratio3.61 EPS Y/Y TTM1.70% Oper. Margin-16559.94% RSI (14)45.37 Volatility3.76% 4.06%
Employees141 Debt/Eq0.28 Sales Y/Y TTM205.11% Profit Margin-15990.68% Recom1.11 Target Price7.17
Option/ShortYes / Yes LT Debt/Eq0.13 EPS Q/Q-14.44% Payout- Rel Volume0.56 Prev Close4.15
Sales Surprise155.80% EPS Surprise2.91% Sales Q/Q2941.38% EarningsNov 07 BMO Avg Volume8.26M Price4.11
SMA20-1.08% SMA50-5.50% SMA20010.09% Trades Volume4,650,348 Change-0.96%
Date Action Analyst Rating Change Price Target Change
Oct-16-24Initiated Scotiabank Sector Outperform
Sep-09-24Initiated Leerink Partners Outperform $7
Apr-30-24Downgrade Robert W. Baird Outperform → Neutral $4.50
Apr-29-24Initiated TD Cowen Buy $10
Mar-15-24Reiterated Needham Buy $4 → $5
Sep-12-23Upgrade Goldman Neutral → Buy $4
Mar-28-23Initiated Goldman Neutral $3
Oct-28-22Initiated Wedbush Outperform $5
Jul-28-22Resumed B. Riley Securities Buy $4
Nov-02-21Initiated Robert W. Baird Outperform $4
Oct-17-24 04:30PM
Oct-15-24 04:30PM
Oct-12-24 12:26PM
Oct-10-24 09:36AM
Oct-09-24 05:27PM
08:04AM Loading…
08:04AM
Sep-19-24 04:30PM
Sep-09-24 04:15PM
Aug-22-24 04:30PM
Aug-08-24 07:00AM
Jul-26-24 07:30AM
Jul-23-24 04:15PM
Jul-18-24 04:30PM
Jul-11-24 02:23PM
Jul-08-24 07:09PM
04:30PM Loading…
Jun-20-24 04:30PM
Jun-11-24 10:00AM
Jun-10-24 11:58AM
Jun-07-24 03:51PM
03:24PM
01:10PM
11:21AM
11:02AM
07:22AM
Jun-06-24 09:58PM
May-16-24 04:30PM
May-03-24 10:34AM
May-02-24 12:55PM
08:20AM
07:00AM
06:46AM Loading…
06:46AM
Apr-25-24 04:30PM
Apr-18-24 04:30PM
Apr-03-24 04:30PM
Mar-19-24 09:07AM
Mar-15-24 03:50PM
01:29PM
10:47AM
08:57AM
05:00AM
Mar-14-24 03:54PM
Mar-13-24 10:48AM
Mar-12-24 12:28PM
Mar-08-24 04:20PM
Feb-28-24 07:05AM
Feb-22-24 04:30PM
Feb-14-24 04:30PM
Jan-18-24 04:30PM
Jan-12-24 08:30AM
Dec-21-23 04:30PM
Dec-11-23 04:15PM
Dec-06-23 08:00AM
Dec-04-23 05:00AM
Nov-28-23 08:00AM
Nov-16-23 04:30PM
Nov-07-23 04:30PM
Nov-02-23 09:00AM
08:00AM
Oct-26-23 04:30PM
Oct-19-23 04:30PM
Oct-12-23 03:26PM
Sep-29-23 08:00AM
Sep-11-23 04:30PM
Sep-07-23 08:00AM
Sep-05-23 04:30PM
Aug-22-23 08:00AM
Aug-21-23 08:00AM
Aug-17-23 04:30PM
Aug-03-23 04:05PM
Jul-27-23 04:30PM
Jul-20-23 04:30PM
Jun-29-23 08:30AM
Jun-22-23 04:30PM
Jun-20-23 09:00AM
Jun-13-23 09:00AM
Jun-12-23 08:00AM
Jun-07-23 04:30PM
Jun-06-23 04:30PM
Jun-02-23 03:30PM
May-25-23 05:02PM
May-18-23 04:30PM
May-11-23 10:02AM
08:00AM
May-04-23 04:30PM
Apr-26-23 10:05AM
Apr-20-23 04:30PM
Apr-12-23 04:40PM
Mar-16-23 05:45PM
04:05PM
Mar-09-23 04:30PM
Feb-16-23 04:30PM
Feb-03-23 01:19PM
Jan-19-23 04:30PM
Jan-12-23 07:30AM
Jan-11-23 07:30AM
Jan-10-23 04:30PM
Jan-05-23 11:15PM
Jan-04-23 04:19PM
06:55AM
Jan-03-23 04:30PM
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GRETHLEIN ANDREW JEVP, Chief Operating OfficerJul 08 '24Option Exercise1.72674,3481,159,879674,348Jul 10 04:05 PM
GRETHLEIN ANDREW JEVP, Chief Operating OfficerJul 08 '24Sale4.56674,3483,073,0040Jul 10 04:05 PM
Feller FayeEVP, Chief Medical OfficerJun 10 '24Option Exercise1.19287,900341,693155,400Jun 12 04:05 PM
Feller FayeEVP, Chief Medical OfficerJun 10 '24Sale4.63287,9001,334,1290Jun 12 04:05 PM
Kapur AnilEVP, Corp Strategy & CCOJun 10 '24Option Exercise1.06421,875447,188421,875Jun 12 04:05 PM
Kapur AnilEVP, Corp Strategy & CCOJun 10 '24Sale4.64421,8751,959,6090Jun 12 04:05 PM
SCARLETT JOHN AChairman, President and CEOJun 04 '24Option Exercise2.54600,0001,524,000600,000Jun 05 04:05 PM
SCARLETT JOHN AChairman, President and CEOJun 04 '24Sale4.00600,0002,400,000600,000Jun 05 04:05 PM
LAWLIS V BRYANDirectorMay 15 '24Option Exercise1.9435,00067,90035,000May 17 04:05 PM
LAWLIS V BRYANDirectorMay 15 '24Sale3.7535,000131,2500May 17 04:05 PM